Correlation Between Grifols SA and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Grifols SA and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grifols SA and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Grifols SA ADR and Novartis AG ADR, you can compare the effects of market volatilities on Grifols SA and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grifols SA with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grifols SA and Novartis.

Diversification Opportunities for Grifols SA and Novartis

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Grifols and Novartis is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Grifols SA ADR and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Grifols SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grifols SA ADR are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Grifols SA i.e., Grifols SA and Novartis go up and down completely randomly.

Pair Corralation between Grifols SA and Novartis

Given the investment horizon of 90 days Grifols SA is expected to generate 1.17 times less return on investment than Novartis. In addition to that, Grifols SA is 1.98 times more volatile than Novartis AG ADR. It trades about 0.05 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about 0.11 per unit of volatility. If you would invest  9,573  in Novartis AG ADR on January 25, 2024 and sell it today you would earn a total of  264.00  from holding Novartis AG ADR or generate 2.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Grifols SA ADR  vs.  Novartis AG ADR

 Performance 
       Timeline  
Grifols SA ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Grifols SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Novartis AG ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novartis AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Novartis is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Grifols SA and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Grifols SA and Novartis

The main advantage of trading using opposite Grifols SA and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grifols SA position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Grifols SA ADR and Novartis AG ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities